IGMS – igm biosciences, inc. (US:NASDAQ)
Stock Stats
News
IGM Biosciences, Inc. (NASDAQ: IGMS) had its price target raised by analysts at Stifel Nicolaus from $25.00 to $27.00. They now have a "buy" rating on the stock.
IGM Biosciences GAAP EPS of -$1.01 misses by $0.19, revenue of $0.52M beats by $0.28M [Seeking Alpha]
IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update
IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]
Medivir AB (OSTO:MVIR) Q3 2024 Earnings Call Highlights: Strategic Collaborations and Financial ... [Yahoo! Finance]
Form 4 IGM Biosciences, Inc. For: Nov 18 Filed by: Tahir Misbah
Form SC 13G/A IGM Biosciences, Inc. Filed by: PRICE T ROWE ASSOCIATES INC /MD/
Form 4 IGM Biosciences, Inc. For: Nov 07 Filed by: Weber Steven
Form SC 13G/A IGM Biosciences, Inc. Filed by: FMR LLC
Form 8-K IGM Biosciences, Inc. For: Nov 08
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.